PrEP Resources

PrEP resources from programs, countries, regulatory bodies and normative agencies

The oral PrEP landscape is moving quickly. More and more programs and countries are moving forward with oral PrEP rollout. This section contains information and materials from the early stages of PrEP introduction around the world.

  • Key Resources - Infographics and resources on PrEP research, uptake and regulatory status
  • Global Guidance - Global guidance helps set expectations, define priorities and can pave the way for national action
  • National Policies and Guidelines - Country-specific policies and guidelines provide detailed information for delivering PrEP effectively in a given context.
  • Oral PrEP Training Materials - Many different types of training curricula and tools are being developed as daily oral PrEP rolls out.
  • Monitoring & Evaluation Materials - Tools to support the implementation and assessment of PrEP.
  • Advocacy Resources - Here’s how groups are taking action demanding PrEP—and how you can get involved!
  • Demand Creation - Taking steps to bring people to your programs—and vice versa.
  • Implementation Resources - Programs already have experience implementing and supporting oral PrEP scale up. Below you will find resources from major players in rollout so far.

Framework for Scaling Up PrEP

Are you planning to introduce PrEP or already rolling out the product? The “Framework for Scaling Up PrEP” outlines steps involved for introducing oral PrEP and provides links to specific tools and resources for the following steps:

value chain graphic

News Spotlight

  • FDA Approves Truvada as PrEP for Adolescents at Risk for HIV

    May 15, 2018

    The US Food and Drug Administration has expanded the approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV to include adolescents. Truvada was approved as an HIV prevention method in 2012 but only for individuals age 18 and older. The new approval expands this indication to include adults and adolescents at risk for HIV.

    Read more

  • Early PrEP Uptake in Africa Study Gives Support for Possibility of Wider Acceptance

    May 9, 2018

    New findings show that nearly a fifth of adults whose risk for HIV infection made them eligible for free PrEP started taking the drug within 30 days — according to a study examining the impacts of health interventions across communities in two East African countries. The study’s authors conclude that this provides further evidence that widespread roll out of PrEP to individuals at high risks for infection across resource-limited communities is feasible.

    Read more